PKM and colorectal carcinoma: In summary, these findings indicate that systemically injected exo‐si‐ciRS‐122 could suppress glycolysis and reverse resistance to oxaliplatin by regulating the ciRS‐122/miR‐122/PKM2 axis in CRC (Fig. 6H).